The invention relates to the technical field of biological detection, and particularly discloses a marker combination for detecting Alzheimer's
disease, which comprises the following markers: beta
amyloid protein 1-40, beta
amyloid protein 1-42, phosphorylated Tau217
protein, phosphorylated Tau181 protein, phosphorylated Tau231 protein, neurofilament light chain protein and colloidal
fiber acidic protein. The invention also discloses application of the marker combination for detecting the Alzheimer's
disease in single molecule detection. The application comprises the following steps: S1, preparing standard solutions with different concentrations of the markers; s2, detecting the standard solutions with different concentrations of each marker by adopting a single molecule array analysis technology, and counting corresponding single molecule
signal numbers; and S3, drawing a
standard curve of each marker according to the single molecule
signal numbers corresponding to the standard solutions with different concentrations of each marker. The method has the advantages that the overall performance of the AD
disease biomarker combination can be accurately evaluated, and the reliability and accuracy of AD
disease markers in clinical application are improved.